Comparison between Akums Drugs IPO and Interarch Building Products IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Interarch Building Products IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Interarch Building Products IPO is up to ₹600.29 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Interarch Building Products IPO is ₹900.00 per share.
| Akums Drugs IPO | Interarch Building Products IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹850.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹900.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹900.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | ₹85.00 per share |
| Market Lot Size | 22 shares | 16 shares |
| Fresh Issue Size | 1,00,37,708 shares | 22,24,539 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹200.14 Cr |
| OFS Issue Size | 1,73,30,435 shares | 44,47,630 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹400.15 Cr |
| Issue Size Total | 2,73,68,143 shares | 66,72,169 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹600.29 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Interarch Building Products IPO opens on Aug 19, 2024. The closing date of Akums Drugs IPO and Interarch Building Products IPO is Aug 01, 2024, and Aug 21, 2024, respectively.
| Akums Drugs IPO | Interarch Building Products IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Aug 16, 2024 |
| Issue Open | Jul 30, 2024 | Aug 19, 2024 |
| Issue Close | Aug 01, 2024 | Aug 21, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Aug 22, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Aug 23, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Aug 23, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Aug 26, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Sep 20, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Nov 19, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Interarch Building Products IPO P/E ratio of 15.04.
| Akums Drugs IPO | Interarch Building Products IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 87.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 59.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.04 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1497.43 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 19.40% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 25.79% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | -0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹59.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 22.26% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Interarch Building Products IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 13,29,526 shares in Interarch Building Products IPO.
| Akums Drugs IPO | Interarch Building Products IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 19,94,288 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 13,29,526 shares |
| NII | 40,68,637 shares | 9,97,145 shares |
| RII | 27,12,424 shares | 23,26,671 shares |
| Employee | 2,43,902 shares | 24,539 shares |
| Others | ||
| Total | 2,73,68,151 shares | 66,72,169 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Interarch Building Products IPO subscribed 93.79x.
| Akums Drugs IPO | Interarch Building Products IPO | |
|---|---|---|
| QIB (times) | 90.09x | 197.29x |
| NII (times) | 42.10x | 130.91x |
| Big NII (times) | 47.43x | 148.31x |
| Small NII (times) | 31.45x | 96.11x |
| RII (times) | 20.80x | 19.46x |
| Employee (times) | 4.14x | 25.75x |
| Other (times) | ||
| Total (times) | 63.44x | 93.79x |
